ADUS logo

ADDUS HOMECARE CORP

ADUSNASDAQ
πŸ† #1966 by market capEarnings Nov 2US Equity
$909.73β–² $0.73 (+0.08%)
Simulated price
πŸ””
Track ADUS
Get earnings, price moves & breaking news on Telegram
Track
24hβ–² 0.1%
7dβ–² 691.0%
14dβ–² 664.4%
30dβ–² 692.9%
ytdβ–² 747.8%
1yβ–² 672.2%
🏦Market Cap
$2.07B
Small Cap
πŸ“ˆRevenue Growth (YoY)
+23.2%
Healthy
πŸ“ŠGross Margin
32.4%
Moderate
πŸ’΅FCF Margin
10.4%
Healthy
βš–οΈP/S Ratio
1.4x
Cheap
Otter Score
76
Good

Trading Snapshot

Day Range
$896.90 – $918.88
52-Week Range
$87.95 – $124.44
Volume
$2.47B
Avg Volume
$2.31B
Shares Outstanding
18.7M
Next Earnings
Dec 8, 2026

Fundamentals Snapshot

Annual Revenue
$1.42B
Last Q Revenue
$377M
P/E Ratio
19.5
P/S Ratio
1.4x
EPS (TTM)
$5.70
Dividend Yield
0.00%
Dilution (1yr)
+0.8%

Why Investors Own ADUS

  • βœ“High-growth profile β€” revenue up +41.8% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 35% gross margin and 5% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

ADUS logo

ADDUS HOMECARE CORP

ADUS
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$1.4Bβ–² +23.2% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
32.5%β–² +0.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$139Mβ–² +35.0% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$104Mβ–Ό βˆ’6.0% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
18.4Mβ–² +0.8% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$127Mβ–² +$47M YoY
StockOtter Β· stockotter.space

About ADDUS HOMECARE CORP

Addus HomeCare Corporation, through its various subsidiaries, offers essential personal support services across the United States. The company primarily assists seniors, individuals with chronic illnesses or disabilities, and those at risk of hospitalization or institutionalization. Its operations are structured into three primary segments: Personal Care, Hospice, and Home Health. The Personal Care division delivers non-medical assistance with daily living activities, including help with personal hygiene (bathing, grooming, oral care), eating, dressing, medication reminders, meal preparation, household chores, and transportation. Through its Hospice segment, Addus provides compassionate palliative nursing care, social work, spiritual guidance, homemaker services, and bereavement support to terminally ill individuals and their families. The Home Health segment delivers professional skilled nursing care alongside physical, occupational, and speech therapy for patients recovering from illness or following a hospital discharge. Addus HomeCare's diverse client base includes federal, state, and local government entities, managed care organizations, commercial insurance providers, and private-paying individuals. As of December 31, 2021, the company served consumers through a network of 206 offices located across 22 states. Established in 1979, Addus HomeCare Corporation is headquartered in Frisco, Texas.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Good
76/100

Analyst Price Target

β“˜
Average Target
$957.90
β–² +5.3% Upside
High Target$1,108.22
Low Target$732.03
Based on 19 analysts

Latest News & Updates